Physician profile
John Edward White
NPI 1205820925
$2,105.90
in general payments reported to CMS, 2019-2025
13 companies · $79.34 in 2025
The $79.34 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.31 · 2022: $734 · 2023: $620 · 2024: $589 · 2025: $79.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.06 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $1,017.94 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $240.30 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $207.66 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $134.43 | 2022-2024 | |
| Hologic Sales and Service, LLC | $120.82 | 2022-2024 | Myosure Tissue Removal Device, Acessa Provu System |
| Novo Nordisk INC | $117.77 | 2023-2025 | Wegovy |
| Minerva Surgical, INC | $78.05 | 2019-2022 | |
| Abbvie INC. | $59.50 | 2022-2023 | Liletta |
| Millicent US INC | $43.20 | 2024-2025 | Intrarosa, Femring |
| Pfizer INC. | $27.96 | 2024 | |
| Exact Sciences Corporation | $20.82 | 2024 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $20.67 | 2019 | |
| Meditrina | $16.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.